|
|||
|
|
|||
|
 |
Important safety information | Prescribing Information | Glossary | |
 | |||
|
How is NovoLog® used in a pump?
What is NovoLog® insulin analog? NovoLog® your trusted insulin analog approved for use in pumps since 2001. It is called an insulin analog because the chemical components of insulin have been slightly modified, which helps the insulin work faster. NovoLog® is similar to the natural insulin that the body makes in people without diabetes (this is called natural or physiologic action). Because it doesn't last as long as regular human insulin, you may need to take an intermediate- or longer-acting insulin or use higher rates of NovoLog® basal insulin infusion in your pump to help avoid hyperglycemia and ketoacidosis. This is especially true for rapid-acting insulin analogs, which is especially important to know if you have been switched from multiple injection therapy or insulin with buffered regular insulin. What are the benefits of using NovoLog® in a pump? NovoLog® works faster at mealtime than regular human insulin, so you can take it and then eat within 5 to 10 minutes. With regular human insulin, you have to wait 30 minutes before you eat. NovoLog® gives you greater dosing options because you can change your insulin regimen when you change your schedule or eating habits. Studies show that NovoLog® is effective and safe when used in pumps by people with type 1 or type 2 diabetes.1,2 NovoLog® may also be used with a variety of other insulin delivery systems that can help make dosing easier. How does NovoLog® work in pumps? Program the pump for NovoLog® basal infusion and mealtime NovoLog® bolus doses according to your doctor's and the manufacturer's instructions. See the Prescribing Information (pi.pdf) for detailed instructions on how to use NovoLog® in an insulin pump. Is using NovoLog® in a pump right for you? Only your doctor can tell you if NovoLog® is the right choice for you. NovoLog® provides effective glucose control with the convenience of mealtime dosing, so it fits easily into any lifestyle. Ask your doctor for more information about NovoLog® . Will Cross, a middle school principal from Pennsylvania, has not let type 1 diabetes stop him from pursuing rugged hiking expeditions in very challenging and dangerous conditions such as the North Pole, Greenland, and Mt. Everest, including his televised NovoLog® ultimate Walk To Cure Diabetes to the South Pole. Here is what Will says about using NovoLog® in the pump: "NovoLog® allows for some welcome flexibility in my diet, which is of particular importance when trekking in extreme environments such as Mt. Everest. — Will Cross* More information about pumps. * Individual results may vary. 1. Raskin P, Bode B, Marks JB, et al. Insulin aspart (IAsp) is as effective in continuous subcutaneous insulin infusion as in multiple daily injections for patients with type 2 diabetes [abstract 515P]. Diabetes. 2001;50(suppl 2):A128. 2. Bode B, Weinstein R, Bell D, et al. Comparison of insulin aspart with buffered regular insulin and insulin lispro in continuous subcutaneous insulin infusion. Diabetes Care. 2002;25:439-444.
|
| |||||||||||
